stockrowEdwards Lifesciences Corporation
Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.
- Revenue
- +10.5%
- EPS
- +6.00%
- Free cash flow
- −1.84%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow EW
Alert me
Edwards Lifesciences Corporation (EW) Revenue growth
Edwards Lifesciences Corporation's revenue growth over the twelve months to 30 September 2026 was 13.4%, up 1.9 percentage points from fiscal 2025 (11.6%). Over the past ten years it has ranged from −14.7% (fiscal 2022) to 19.3% (fiscal 2021); the current reading is higher than 55% of that period. That is above the Medical Devices industry median of 10.4% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 11.6% | 2.98 |
| FY2024 | 8.57% | (3.66) |
| FY2023 | 12.2% | 26.92 |
| FY2022 | −14.7% | (33.98) |
| FY2021 | 19.3% | 18.41 |
| FY2020 | 0.88% | (15.91) |
| FY2019 | 16.8% | 8.42 |
| FY2018 | 8.37% | (7.54) |
| FY2017 | 15.9% | (2.94) |
| FY2016 | 18.9% | 11.50 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 10.5% | (3.17) |
| Jun 2026 | 13.6% | (3.07) |
| Mar 2026 | 16.7% | 3.44 |
| Dec 2025 | 13.3% | (1.41) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| EW Edwards Lifesciences Corporation | 13.4% |
| DXCM DexCom, Inc. compare | 13.0% |
| MDT Medtronic PLC compare | 9.77% |
| BSX Boston Scientific Corporation compare | 8.87% |
| STE STERIS plc compare | 8.12% |
| PHG Koninklijke Philips N.V. compare | 7.98% |
| SYK Stryker Corporation compare | 7.87% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.98% |
| GEHC GE HealthCare Technologies Inc. compare | 6.87% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on EW
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement